1. Implementation, intervention, and downstream costs for implementation of a multidisciplinary complex pain clinic in the Veterans Health Administration
- Author
-
Daniels, Sarah I., Cave, Shayna, Wagner, Todd H., Perez, Taryn A., Edmond, Sara N., Becker, William C., and Midboe, Amanda M.
- Subjects
United States. Veterans Health Administration -- Services ,Medical care, Cost of -- Analysis ,Chronic pain -- Demographic aspects -- Care and treatment ,Pain clinics -- Planning -- Economic aspects -- Services ,Company business planning ,Business ,Health care industry - Abstract
Objective: To determine the budget impact of implementing multidisciplinary complex pain clinics (MCPCs) for Veterans Health Administration (VA) patients living with complex chronic pain and substance use disorder comorbidities who are on risky opioid regimens. Data Sources and Study Setting: We measured implementation costs for three MCPCs over 2 years using micro-costing methods. Intervention and downstream costs were obtained from the VA Managerial Cost Accounting System from 2 years prior to 2 years after opening of MCPCs. Study Design: Staff at the three VA sites implementing MCPCs were supported by Implementation Facilitation. The intervention cohort was patients at MCPC sites who received treatment based on their history of chronic pain and risky opioid use. Intervention costs and downstream costs were estimated with a quasi-experimental study design using a propensity score-weighted difference-in-difference approach. The healthcare utilization costs of treated patients were compared with a control group having clinically similar characteristics and undergoing the standard route of care at neighboring VA medical centers. Cancer and hospice patients were excluded. Data Collection/Extraction Methods: Activity-based costing data acquired from MCPC sites were used to estimate implementation costs. Intervention and downstream costs were extracted from VA administrative data. Principal Findings: Average Implementation Facilitation costs ranged from $380 to $640 per month for each site. Upon opening of three MCPCs, average intervention costs per patient were significantly higher than the control group at two intervention sites. Downstream costs were significantly higher at only one of three intervention sites. Site-level differences were due to variation in inpatient costs, with some confounding likely due to the COVID-19 pandemic. This evidence suggests that necessary start-up investments are required to initiate MCPCs, with allocations of funds needed for implementation, intervention, and downstream costs. Conclusions: Incorporating implementation, intervention, and downstream costs in this evaluation provides a thorough budget impact analysis, which decision-makers may use when considering whether to expand effective programming. KEYWORDS chronic pain, costs and cost analysis, economic evaluation, healthcare costs, implementation science What is known on this topic * Opioid-related morbidity and mortality affect over 2 million Americans per year and have extraordinarily high economic and societal costs. * Healthcare systems urgently need treatment models that address patients living with chronic pain who are prescribed opioids and have substance use disorders. * Healthcare decision-makers need cost information to determine how and when to implement multidisciplinary clinics for those living with complex chronic pain. What this study adds * This study evaluates the initial start-up costs of implementing a multidisciplinary pain clinic for patients living with complex chronic pain and taking risky opioids at three distinct VA hospitals, relying on Implementation Facilitation. * Implementation of multidisciplinary complex pain clinics require fairly little funding for implementation costs and more substantial funding for intervention and downstream costs to meet the needs of serving patients living with complex chronic pain. * Relatively similar budget impacts were observed at the facility-level across all three disparate VA sites, demonstrating robust estimates when presenting this clinic to decision-makers at new sites., 1 | INTRODUCTION Opioid use disorder (OUD) and opioid overdose deaths in the United States were estimated to cost $1.02 trillion in 2017, which includes healthcare-related costs and losses in [...]
- Published
- 2024
- Full Text
- View/download PDF